SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-Jun-24 4:09 PM View: | Aura Biosciences, Inc. (AURA) | 20-Jun-24 | Grant | 10,500 | -- | -- | 100% 0 to 10.5K | |
06-Feb-24 6:26 PM View: | Ocular Therapeutix, Inc (OCUL) | 05-Feb-24 | Sale | 19,642 | $4.86 | $95,460.10 | 3% 575.56K to 595.2K | |
06-Feb-24 6:26 PM View: | Ocular Therapeutix, Inc (OCUL) | 03-Feb-24 | Grant | 180,400 | -- | -- | 42% 434.44K to 614.84K | |
02-Feb-24 7:00 PM View: | Ocular Therapeutix, Inc (OCUL) | 31-Jan-24 | Sale | 18,338 | $4.95 | $90,773.10 | (4%) 452.78K to 434.44K | |
05-Sep-23 8:27 AM View: | Ocular Therapeutix, Inc (OCUL) | 30-Aug-23 | Private Purchase | 6,500 | $3.81 | $24,765.00 | 1% 446.28K to 452.78K | |
08-Feb-23 7:29 PM View: | Ocular Therapeutix, Inc (OCUL) | 06-Feb-23 | Sale (Planned) | 19,669 | $4.24 | $83,396.60 | (4%) 465.95K to 446.28K | |
01-Feb-23 7:32 PM View: | Ocular Therapeutix, Inc (OCUL) | 30-Jan-23 | Grant | 176,300 | -- | -- | 61% 289.65K to 465.95K | |
07-Feb-22 7:28 PM View: | Ocular Therapeutix, Inc (OCUL) | 03-Feb-22 | Grant | 186,750 | -- | -- | 181% 102.9K to 289.65K | |
24-Aug-21 8:49 AM View: | Ocular Therapeutix, Inc (OCUL) | 20-Aug-21 | Market Purchase | 5,000 | $9.89 | $49,450.00 | 5% 97.9K to 102.9K | 5% |
10-Jun-19 4:53 PM View: | Ocular Therapeutix, Inc (OCUL) | 06-Jun-19 | Market Purchase | 40,000 | $2.81 | $112,400.00 | 69% 57.9K to 97.9K | 690% |
21-Aug-18 4:30 PM View: | Ocular Therapeutix, Inc (OCUL) | 20-Aug-18 | Market Purchase | 20,000 | $5.95 | $119,000.00 | 53% 37.9K to 57.9K | 273% |
13-Aug-18 4:43 PM View: | Ocular Therapeutix, Inc (OCUL) | 10-Aug-18 | Market Purchase | 16,900 | $6.23 | $105,287.00 | 80% 21.0K to 37.9K | 256% |
13-Dec-17 5:15 PM View: | Ocular Therapeutix, Inc (OCUL) | 12-Dec-17 | Market Purchase | 21,000 | $4.29 | $90,090.00 | 100% 0 to 21.0K | 418% |